The influence of Memantine on the microenvironment of osteoporosis

Osteoporosis is a systemic bone disease primarily caused by an imbalance in osteoclastogenesis. The inhibition of osteoclast formation and function is crucial for the treatment of osteoporosis. Memantine, an NMDAR antagonist mainly used to treat Alzheimer's disease (AD), has an unclear role in osteoporosis.